SMARCAL1 and central nervous system cancer: In Glioma, LUAD, LIHC, KIRC, and UCEC, SMARCAL1 expression exhibited significant correlations with forty-two, thirty-two, twenty-four, fifty, and eighty-three drugs, respectively (|R|> 0.3, p < 0.05, Additional file 1: Supplementary Table S5).